Fig. 1From: Sulfadiazine plasma concentrations in women with pregnancy-acquired compared to ocular toxoplasmosis under pyrimethamine and sulfadiazine therapy: a case–control studyBoxplots of observed concentrations of pyrimethamine (a) and sulfadiazine (b) versus time during the early treatment phase in female patients with acute ocular toxoplasmosis (OT). Red lines: lower and upper target concentrations of pyrimethamine (700 and 1300 µg/l)14 and sulfadiazine (50 and 150 mg/l)21Back to article page